- Home
- XNCR vs HELE Comparison
XNCR vs HELE Comparison
Compare XNCR & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- HELE
- Stock Information
- Founded
- XNCR 1997
- HELE 1968
- Country
- XNCR United States
- HELE United States
- Employees
- XNCR N/A
- HELE N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- HELE Home Furnishings
- Sector
- XNCR Health Care
- HELE Consumer Discretionary
- Exchange
- XNCR Nasdaq
- HELE Nasdaq
- Market Cap
- XNCR 1.7B
- HELE 1.6B
- IPO Year
- XNCR 2013
- HELE N/A
- Fundamental
- Price
- XNCR $24.20
- HELE $63.08
- Analyst Decision
- XNCR Strong Buy
- HELE Buy
- Analyst Count
- XNCR 9
- HELE 3
- Target Price
- XNCR $36.33
- HELE $80.67
- AVG Volume (30 Days)
- XNCR 850.2K
- HELE 395.0K
- Earning Date
- XNCR 11-06-2024
- HELE 01-06-2025
- Dividend Yield
- XNCR N/A
- HELE N/A
- EPS Growth
- XNCR N/A
- HELE 5.17
- EPS
- XNCR N/A
- HELE 6.03
- Revenue
- XNCR $85,164,000.00
- HELE $1,929,883,000.00
- Revenue This Year
- XNCR N/A
- HELE N/A
- Revenue Next Year
- XNCR $89.22
- HELE $1.95
- P/E Ratio
- XNCR N/A
- HELE $10.42
- Revenue Growth
- XNCR N/A
- HELE N/A
- 52 Week Low
- XNCR $15.31
- HELE $48.05
- 52 Week High
- XNCR $27.24
- HELE $127.83
- Technical
- Relative Strength Index (RSI)
- XNCR 44.92
- HELE 31.74
- Support Level
- XNCR $22.74
- HELE $66.06
- Resistance Level
- XNCR $25.54
- HELE $75.68
- Average True Range (ATR)
- XNCR 1.17
- HELE 2.25
- MACD
- XNCR -0.33
- HELE -1.34
- Stochastic Oscillator
- XNCR 22.00
- HELE 5.76
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About HELE Helen of Troy Limited
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.